Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Varian Medical Systems stock price, quote, forecast and news

VAR
US92220P1057
852812

Price

177.07
Today +/-
+0
Today %
+0 %
P

Varian Medical Systems Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Varian Medical Systems, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Varian Medical Systems from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Varian Medical Systems’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Varian Medical Systems. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Varian Medical Systems’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Varian Medical Systems’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Varian Medical Systems’s growth potential.

Varian Medical Systems Revenue, EBIT and net profit per share

DateVarian Medical Systems RevenueVarian Medical Systems EBITVarian Medical Systems Net Income
2025e5.37 B undefined0 undefined918.39 M undefined
2024e4.88 B undefined0 undefined826.55 M undefined
2023e4.49 B undefined0 undefined642.87 M undefined
2022e4.02 B undefined0 undefined551.03 M undefined
2021e3.61 B undefined0 undefined459.19 M undefined
20203.17 B undefined424.8 M undefined269.2 M undefined
20193.23 B undefined503.5 M undefined291.9 M undefined
20182.92 B undefined496.2 M undefined149.9 M undefined
20172.62 B undefined377.6 M undefined218.5 M undefined
20162.59 B undefined437.4 M undefined399.3 M undefined
20152.49 B undefined378.7 M undefined411.5 M undefined
20143.05 B undefined582.6 M undefined403.7 M undefined
20132.94 B undefined618.5 M undefined438.2 M undefined
20122.81 B undefined594.1 M undefined427 M undefined
20112.6 B undefined588.5 M undefined398.9 M undefined
20102.36 B undefined534.2 M undefined360.4 M undefined
20092.21 B undefined474.1 M undefined319 M undefined
20082.07 B undefined419.4 M undefined279.5 M undefined
20071.78 B undefined335.2 M undefined239.5 M undefined
20061.6 B undefined309.4 M undefined245.1 M undefined
20051.38 B undefined305 M undefined206.6 M undefined
20041.24 B undefined256 M undefined167.2 M undefined
20031.04 B undefined198.4 M undefined130.9 M undefined
2002873.1 M undefined144.8 M undefined93.6 M undefined
2001773.6 M undefined109.5 M undefined54.3 M undefined

Varian Medical Systems Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021e2022e2023e2024e2025e
0.760.930.970.890.981.171.341.261.381.291.311.551.581.61.431.420.590.690.770.871.041.241.381.61.782.072.212.362.62.812.943.052.492.592.622.923.233.173.614.024.494.885.37
-22.914.74-8.3310.2119.1414.79-5.888.94-6.461.7918.381.481.52-10.88-0.21-58.5116.7812.1912.9419.2418.6411.9015.5611.2116.507.016.4110.198.134.813.64-18.334.141.0011.4510.48-1.7714.0811.3411.588.7110.02
34.7034.8131.1727.3831.1630.7728.3731.0132.9732.3033.1033.5134.9837.7136.7036.9235.5937.3037.1338.8340.4441.8642.9141.5241.3342.3943.3643.5143.7242.6142.4542.6741.4542.5842.5043.6142.4843.47-----
0.260.320.30.240.310.360.380.390.450.420.430.520.550.60.520.530.210.260.290.340.420.520.590.660.730.880.961.031.141.21.251.31.031.11.111.271.371.3800000
739457-18286966831006578130166190129115548910914419825630530933541947453458859461858237843737749650342400000
9.6710.135.86-2.022.855.904.916.577.265.055.958.3810.5411.889.058.099.1512.9214.1016.4919.0220.7322.0719.3518.8620.2521.4122.6722.6521.1621.0119.0915.1816.8514.3916.9915.6013.38-----
445926-14212731-45738457913912211573-24535493130167206245239279319360398427438403411399218149291269459551642826918
-34.09-55.93-153.85-250.0028.5714.81-112.90-1,525.00-33.3318.4275.5675.95-12.23-5.74-36.52-132.88-320.831.8972.2239.7828.4623.3518.93-2.4516.7414.3412.8510.567.292.58-7.991.99-2.92-45.36-31.6595.30-7.5670.6320.0416.5228.6611.14
167.4176175.7170.3174.7175.5165.3156.3156.2151.6145.2142.7140.8128.3125.8121.7122.1129.7136.9140.5142.2142.2137.8135.4130.6127.6125124118.7113.5110.1105.3100.69693.292.591.991.500000
-------------------------------------------
Details

Keystats

Revenue and Growth

The Varian Medical Systems Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Varian Medical Systems is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Varian Medical Systems provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Varian Medical Systems's financial health and stability.

Assets

Varian Medical Systems's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Varian Medical Systems must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Varian Medical Systems after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Varian Medical Systems's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020
-14212731-45738457913912211573-24535493130167206245239279319360398427438403412399219150292269
3843434245454949525546454237222219202527293236444852616262687976729398
107131612-8-271-9-5-20-1-13-15-985-6323-223035-2-3155-28-23481826
-7-1-38-1350-3536-120-3-89-65910-23745-6-14-52-175-88-24-55-51-85-88-65-150-12101-15211
5-20-220153-4-47-2-417-279572022392743434750464158435548551398212077
867101486666678744444443322232771094311
5-19428151422143709464271012124563286448981171351371391342031401191551448612897
2260396011685130891201177744127-3383118156209233251201300372304460472492455449469356399454371484
-50-46-43-49-54-59-48-45-62-65-67-55-47-39-19-16-25-18-24-43-41-64-81-62-67-70-61-76-89-91-80-59-47-58-84
-46-52-4-75-43-25-52-57-51125-7349-14312-21-18-181-84-6051-11-55-87-77-74-117-122-96-133-210-109-130-174-631-140
3-638-261134-3-1211191-5104-9652-2-2-155-65-3595298-6-15-7-47-61-20-43-119-28-71-127-573-56
00000000000000000000000000000000000
165-3759-21-9-1723-18-3227650-350000-5-214-50-36154-36345-6858167-314-350393-55
211-9-50-18-17-38-45-36-184-39-56-34152338-31-68-155-189-196-274-132-73-413-367-197-290-528-331-400-222-121-103-10
1412-513-45-33-62-28-61-196-46-4019-104-1137-31-68-142-194-155-240-142-71-422-311-23451-595-276-245-392-487279-93
1000-100000002-11600001304319406-15-97-1-31-4-12144-15-10-27
-5-5-5-5-5-5-6-6-7-8-9-10-14-3000000000000000000000
-520-16-112628126543-40597-12458135-58502811029-9134156-3344140413-268-3-2-127-20227241
00000000000000000000000000000000000
00000000000000000000000000000000000

Varian Medical Systems stock margins

The Varian Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Varian Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Varian Medical Systems.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Varian Medical Systems's sales revenue. A higher gross margin percentage indicates that the Varian Medical Systems retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Varian Medical Systems's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Varian Medical Systems's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Varian Medical Systems's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Varian Medical Systems. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Varian Medical Systems's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Varian Medical Systems Margin History

Varian Medical Systems Gross marginVarian Medical Systems Profit marginVarian Medical Systems EBIT marginVarian Medical Systems Profit margin
2025e43.47 %0 %17.1 %
2024e43.47 %0 %16.93 %
2023e43.47 %0 %14.32 %
2022e43.47 %0 %13.69 %
2021e43.47 %0 %12.7 %
202043.47 %13.41 %8.5 %
201942.49 %15.61 %9.05 %
201843.63 %17 %5.14 %
201742.53 %14.42 %8.34 %
201642.59 %16.86 %15.39 %
201541.44 %15.2 %16.52 %
201442.68 %19.1 %13.24 %
201342.46 %21.02 %14.89 %
201242.62 %21.16 %15.21 %
201143.74 %22.66 %15.36 %
201043.52 %22.67 %15.29 %
200943.38 %21.41 %14.41 %
200842.4 %20.26 %13.5 %
200741.34 %18.87 %13.48 %
200641.51 %19.36 %15.34 %
200542.89 %22.06 %14.94 %
200441.89 %20.72 %13.53 %
200340.5 %19.05 %12.57 %
200238.86 %16.58 %10.72 %
200137.1 %14.15 %7.02 %

Varian Medical Systems Stock Sales Revenue, EBIT, Earnings per Share

The Varian Medical Systems earnings per share therefore indicates how much revenue Varian Medical Systems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Varian Medical Systems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Varian Medical Systems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Varian Medical Systems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Varian Medical Systems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Varian Medical Systems Revenue, EBIT and net profit per share

DateVarian Medical Systems Sales per ShareVarian Medical Systems EBIT per shareVarian Medical Systems Earnings per Share
2025e58.48 undefined0 undefined10 undefined
2024e53.16 undefined0 undefined9 undefined
2023e48.9 undefined0 undefined7 undefined
2022e43.82 undefined0 undefined6 undefined
2021e39.36 undefined0 undefined5 undefined
202034.63 undefined4.64 undefined2.94 undefined
201935.09 undefined5.48 undefined3.18 undefined
201831.56 undefined5.36 undefined1.62 undefined
201728.1 undefined4.05 undefined2.34 undefined
201627.02 undefined4.56 undefined4.16 undefined
201524.76 undefined3.76 undefined4.09 undefined
201428.96 undefined5.53 undefined3.83 undefined
201326.73 undefined5.62 undefined3.98 undefined
201224.73 undefined5.23 undefined3.76 undefined
201121.88 undefined4.96 undefined3.36 undefined
201019 undefined4.31 undefined2.91 undefined
200917.71 undefined3.79 undefined2.55 undefined
200816.22 undefined3.29 undefined2.19 undefined
200713.6 undefined2.57 undefined1.83 undefined
200611.8 undefined2.29 undefined1.81 undefined
200510.03 undefined2.21 undefined1.5 undefined
20048.69 undefined1.8 undefined1.18 undefined
20037.32 undefined1.4 undefined0.92 undefined
20026.21 undefined1.03 undefined0.67 undefined
20015.65 undefined0.8 undefined0.4 undefined

Varian Medical Systems business model

Varian Medical Systems Inc is a global leader in the field of medical technology, specializing in the development and manufacture of medical devices and solutions for cancer treatment. The company was founded in 1948 as Varian Associates and initially focused on manufacturing electron accelerators for scientific research and medical diagnostics. Today, the company is headquartered in Palo Alto, California, and employs over 10,000 people worldwide. Varian Medical Systems' business model is to provide innovative technologies and devices for radiotherapy and proton therapy to cure cancer patients worldwide. The company specializes in three main areas: oncology systems, proton therapy, and imaging systems. Each of these divisions offers specialized products and solutions to enable effective cancer treatment. In the field of oncology systems, Varian Medical Systems offers a wide range of devices and solutions tailored to the different requirements of various cancer treatments. The company specializes in the development of linac systems, which are used as radiation sources for radiotherapy. These systems are offered in various configurations to provide customized solutions for specific patient needs. Another important area of Varian Medical Systems is proton therapy. This type of radiation therapy offers the advantage of higher precision compared to conventional radiation therapy, resulting in less impact on healthy tissue. Varian Medical Systems has played a leading role in the development of proton therapy systems and now offers a variety of solutions and devices to treat cancer patients worldwide. Varian Medical Systems has also developed solutions in the field of imaging that enable fast and precise detection of cancer and other diseases. These imaging systems allow a wide range of examinations, from early cancer diagnosis to treatment monitoring. In addition to these main areas, Varian Medical Systems has developed a range of products and solutions to improve cancer patient care. This includes clinical IT systems that can enhance patient care by providing health data and analysis. Overall, Varian Medical Systems Inc is a leading company in the field of medical technology, specializing in the development of cancer-fighting solutions. The company offers a wide range of products and solutions tailored to the specific requirements of cancer treatment, contributing to improving the lives of millions of cancer patients worldwide. The world-leading medical technology company Varian Medical Systems Inc specializes in developing and manufacturing medical equipment and solutions for cancer treatment. Originally founded as Varian Associates in 1948, the company began manufacturing electron accelerators for scientific research and medical diagnostics. Today, it is headquartered in Palo Alto, California, and employs over 10,000 people worldwide. Varian Medical Systems' business model revolves around providing innovative technologies and devices for radiotherapy and proton therapy to heal cancer patients globally. The company specializes in three main areas: oncology systems, proton therapy, and imaging systems. Each division offers specialized products and solutions to facilitate effective cancer treatment. In the field of oncology systems, Varian Medical Systems offers a diverse range of devices and solutions tailored to the unique requirements of different cancer treatments. The company specializes in developing Linac systems, which function as radiation sources for radiotherapy. These systems are available in various configurations to ensure customized solutions according to patients' specific needs. Proton therapy is another significant area for Varian Medical Systems. This form of radiation treatment offers higher precision than conventional radiation therapy, resulting in less damage to healthy tissues. Varian Medical Systems has played a leading role in developing proton therapy systems and currently provides a wide range of solutions and devices for cancer treatment worldwide. The company has also developed imaging solutions that enable rapid and accurate cancer detection, along with other medical conditions. These imaging systems provide a broad spectrum of examinations, ranging from early cancer diagnosis to treatment monitoring. In addition to its main areas of focus, Varian Medical Systems has developed various products and solutions aimed at enhancing cancer patient care. This includes clinical IT systems that improve patient care by providing health data and analysis. In conclusion, Varian Medical Systems Inc is a leading global medical technology company specializing in developing cancer treatment solutions. The company offers a wide range of products and solutions tailored to the specific requirements of cancer treatment, ultimately improving the lives of millions of cancer patients worldwide. Varian Medical Systems is one of the most popular companies on Eulerpool.com.

Varian Medical Systems SWOT Analysis

Strengths

1. Industry Leader: Varian Medical Systems Inc is a well-established company and a global leader in providing medical devices and solutions in the healthcare industry.

2. Technological Innovation: Varian is known for its cutting-edge technology and continuous investment in research and development, allowing the company to stay ahead of competitors.

3. Diversified Product Portfolio: The company offers a wide range of products and solutions, including radiation therapy systems, software, and oncology services, catering to different customer needs.

4. Strong Market Presence: Varian has a strong presence in both developed and emerging markets, enabling it to reach a large customer base and capitalize on growing healthcare demands.

Weaknesses

1. Dependence on Healthcare Industry: Varian's success heavily relies on the healthcare industry's spending, making the company vulnerable to economic downturns or changes in healthcare policies.

2. High Research and Development Costs: While investing in innovation is a strength, the associated costs can put a strain on Varian's financials, especially if competitors develop comparable solutions at lower costs.

3. Product Recalls and Safety Concerns: Any product recalls or safety issues could significantly damage Varian's reputation and customer trust, impacting sales and market share.

Opportunities

1. Growing Oncology Market: With increasing incidences of cancer and advancements in treatments, there is a significant opportunity for Varian to expand its oncology-focused product line and services.

2. Emerging Markets Expansion: Varian can further penetrate emerging markets with rising healthcare expenditures to improve patient access to advanced medical technologies and gain new revenue streams.

3. Strategic Partnerships: Collaborating with hospitals, research institutions, and other healthcare organizations can lead to shared expertise, access to new markets, and the development of innovative solutions.

Threats

1. Intense Competition: Varian faces fierce competition from other medical device companies, which may offer similar products or services at lower prices, threatening the company's market share.

2. Regulatory and Reimbursement Changes: Changes in government regulations or reimbursement policies can impact Varian's ability to effectively sell and generate revenue from its medical devices and solutions.

3. Economic Volatility: Economic uncertainty, such as recessions or fluctuations in currency exchange rates, can lead to reduced healthcare investments and adversely affect Varian's sales and profitability.

Varian Medical Systems historical P/E ratio, EBIT, and P/S ratio.

Varian Medical Systems shares outstanding

The number of shares was Varian Medical Systems in 2023 — This indicates how many shares 91.5 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Varian Medical Systems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Varian Medical Systems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Varian Medical Systems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Varian Medical Systems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Varian Medical Systems Stock splits

In Varian Medical Systems's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Varian Medical Systems.

Most common questions regarding Varian Medical Systems

What values and corporate philosophy does Varian Medical Systems represent?

Varian Medical Systems Inc represents values of innovation, integrity, and dedication to improving cancer care worldwide. With a strong corporate philosophy of advancing the fight against cancer, Varian strives to develop transformative solutions in radiotherapy, proton therapy, and brachytherapy. The company is committed to providing cutting-edge technologies, including advanced software and hardware, to enable more precise cancer treatments and better patient outcomes. Varian also emphasizes collaboration and partnerships with healthcare professionals and institutions to continually drive advancements in cancer care. Overall, Varian Medical Systems Inc's values and corporate philosophy revolve around revolutionizing cancer treatment and improving the lives of cancer patients.

In which countries and regions is Varian Medical Systems primarily present?

Varian Medical Systems Inc is primarily present in numerous countries and regions worldwide. It has a strong global presence with operations in North America, Europe, Asia-Pacific, and Latin America. The company serves customers in over 100 countries, including the United States, Canada, Germany, France, United Kingdom, China, Japan, India, Australia, and Brazil, among others. With its extensive network and commitment to delivering innovative medical solutions, Varian Medical Systems Inc continues to make a significant impact in the healthcare industry across various geographies.

What significant milestones has the company Varian Medical Systems achieved?

Varian Medical Systems Inc, a leading global manufacturer of medical devices and software, has achieved several significant milestones. The company revolutionized cancer treatment with the introduction of the first linear accelerator in 1953, paving the way for modern radiation therapy. In 1999, Varian launched the Trilogy system, a versatile radiotherapy solution. In recent years, the company expanded its portfolio, introducing advanced imaging tools like the TrueBeam system. Varian also made strides in the field of proton therapy, developing the ProBeam system that delivers precise radiation doses. Furthermore, the company has made acquisitions and partnerships to enhance its capabilities and expand its reach. Varian Medical Systems Inc maintains an impressive track record of innovating healthcare technologies.

What is the history and background of the company Varian Medical Systems?

Varian Medical Systems Inc. is a renowned medical technology company with a rich history and impressive background. Established in 1948, Varian has made significant contributions to the field of cancer treatment and radiotherapy. Headquartered in Palo Alto, California, the company has become a global leader in providing advanced solutions for oncology care. Varian's innovative products and services help healthcare professionals deliver precise and effective cancer treatments, improving patient outcomes worldwide. With a strong focus on research and development, Varian continues to revolutionize the field of medical technology, empowering healthcare providers to combat cancer and enhance the lives of patients.

Who are the main competitors of Varian Medical Systems in the market?

The main competitors of Varian Medical Systems Inc in the market are Elekta AB, Accuray Incorporated, and Siemens Healthineers AG.

In which industries is Varian Medical Systems primarily active?

Varian Medical Systems Inc is primarily active in the healthcare industry.

What is the business model of Varian Medical Systems?

The business model of Varian Medical Systems Inc is focused on developing and manufacturing medical devices and software for the treatment of cancer and other medical conditions. With a wide product portfolio including radiotherapy systems, software solutions, and imaging systems, Varian Medical Systems Inc aims to provide advanced treatment options to healthcare professionals and improve patient outcomes. By combining technical expertise, research and development, and partnerships with healthcare providers, Varian Medical Systems Inc strives to enhance the delivery of cancer care worldwide.

What is the P/E ratio of Varian Medical Systems 2024?

The Varian Medical Systems P/E ratio is 19.6.

What is the P/S ratio of Varian Medical Systems 2024?

The Varian Medical Systems P/S ratio is 3.32.

What is the AlleAktien quality score of Varian Medical Systems?

The AlleAktien quality score for Varian Medical Systems is 6/10.

What is the revenue of Varian Medical Systems 2024?

The expected Varian Medical Systems revenue is 4.88 B USD.

How high is the profit of Varian Medical Systems 2024?

The expected Varian Medical Systems profit is 826.55 M USD.

What is the business model of Varian Medical Systems

Varian Medical Systems Inc is a leading provider of medical devices and software solutions for cancer treatment. The company is headquartered in Palo Alto, California, and operates worldwide in over 70 countries. Varian operates in three business segments: Oncology Systems, Proton Solutions, and Imaging Components. Oncology Systems is the core business, offering products and services for radiation therapy, including linear accelerators, software solutions, accessories, and aftermarket services. Proton Solutions includes products and services for proton therapy, including proton accelerators and proton therapy software. Imaging Components includes X-ray machines, X-ray detectors, and other components for medical imaging applications. Varian is a leading provider of linear accelerators for radiation therapy and also offers software solutions to help doctors optimize radiation therapy plans and precisely control treatment. In the field of proton therapy, Varian is a leading provider of proton accelerators used for cancer treatment. This technology is particularly suitable for treating tumors near sensitive organs and tissues and offers higher precision than conventional radiation therapy. In the field of medical imaging, Varian is a leading provider of X-ray components such as X-ray machines and detectors. These products are used in a variety of medical applications to provide detailed images of the body, assisting doctors in the diagnosis and treatment of diseases. Varian also offers aftermarket services, including maintenance and repair services, as well as upgrades and spare parts for its products. These services are important to ensure that Varian's equipment remains safe and effective with a long lifespan. Overall, Varian has a strong business model based on advanced medical technology and software solutions. The company is well positioned to benefit from the increasing demand for cancer treatments and the growing acceptance of proton therapy. Furthermore, Varian's strong aftermarket service offering provides high customer satisfaction and helps the company build long-term relationships with its customers.

What is the Varian Medical Systems dividend?

Varian Medical Systems pays a dividend of 0 USD distributed over payouts per year.

How often does Varian Medical Systems pay dividends?

The dividend cannot currently be calculated for Varian Medical Systems or the company does not pay out a dividend.

What is the Varian Medical Systems ISIN?

The ISIN of Varian Medical Systems is US92220P1057.

What is the Varian Medical Systems WKN?

The WKN of Varian Medical Systems is 852812.

What is the Varian Medical Systems ticker?

The ticker of Varian Medical Systems is VAR.

How much dividend does Varian Medical Systems pay?

Over the past 12 months, Varian Medical Systems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Varian Medical Systems is expected to pay a dividend of 0 USD.

What is the dividend yield of Varian Medical Systems?

The current dividend yield of Varian Medical Systems is .

When does Varian Medical Systems pay dividends?

Varian Medical Systems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Varian Medical Systems?

Varian Medical Systems paid dividends every year for the past 0 years.

What is the dividend of Varian Medical Systems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Varian Medical Systems located?

Varian Medical Systems is assigned to the 'Health' sector.

Wann musste ich die Aktien von Varian Medical Systems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Varian Medical Systems from 7/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Varian Medical Systems pay the last dividend?

The last dividend was paid out on 7/23/2024.

What was the dividend of Varian Medical Systems in the year 2023?

In the year 2023, Varian Medical Systems distributed 0 USD as dividends.

In which currency does Varian Medical Systems pay out the dividend?

The dividends of Varian Medical Systems are distributed in USD.

All fundamentals about Varian Medical Systems

Our stock analysis for Varian Medical Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Varian Medical Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.